TriLytewith Flavor Packs (Wallace Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the TriLyte drug offered from Wallace Pharmaceuticals Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Wallace Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Polyethylene glyocol 3350, sodium chloride, sodium bicarbonate and potassium chloride
SUBSTANCE NAME: POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: NASOGASTRIC; ORAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-09-23
END MARKETING DATE: 0000-00-00


TriLyte with Flavor Packs HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTriLyte with Flavor Packs from Wallace Pharmaceuticals Inc.
LABELER NAME: Wallace Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 420; 11.2; 5.72; 1.48(g/4L; g/4L; g/4L; g/4L)
START MARKETING DATE: 2013-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51525-6831_486598b0-0358-11e3-8ffd-0800200c9a66
PRODUCT NDC: 51525-6831
APPLICATION NUMBER: ANDA076491

Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Affordable Pharmaceuticals, LLCPEG-3350, sodium chloride, sodium bicarbonate and potassium chloride
Alaven Pharmaceutical LLCTRILYTE
GAVIS Pharmaceuticals, LLCGaviLyte – N
Novel Laboratories, Inc.Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate
Strides Shasun LimitedPolyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride – Unflavored
Wallace Pharmaceuticals Inc.TriLyte